[Pharmacology and clinical pharmacokinetics of nadolol].
D000319:Adrenergic beta-Antagonists / Q000378:metabolism* / Q000627:therapeutic use; D001682:Biological Availability; D055598:Chemical Phenomena; D002621:Chemistry; D006207:Half-Life; D006801:Humans; D007700:Kinetics; D008657:Metabolic Clearance Rate; D009248:Nadolol; D011412:Propanolamines / Q000378:metabolism* / Q000627:therapeutic use
D000319:Adrenergic beta-Antagonists; D011412:Propanolamines; D009248:Nadolol
Farmakologia i farmakokinetyka kliniczna nadololu.